@article{fb5876a87bfd48bb829fd79e44021aae,
title = "Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies",
keywords = "EDFR, TKI, COX-21, erlotinib, celecoxib, chemopreventive",
author = "Shin, \{D. M.\} and H. Zhang and Saba, \{N. F.\} and Chen, \{A. Y.\} and S. Nannapaneni and Amin, \{Arm R.\} and S. M{\"u}ller and M. Lewis and G. Sica and S. Kono and Brandes, \{J. C.\} and Grist, \{W. J.\} and R. Moreno-Williams and Beitler, \{J. J.\} and Thomas, \{S. M.\} and Z. Chen and Shin, \{H. J.\} and Grandis, \{J. R.\} and Khuri, \{F. R.\} and Chen, \{Z. G.\}",
note = "Shin DM, Zhang H, Saba NF, Chen AY, Nannapaneni S, Amin AR, M{\"u}ller S, Lewis M, Sica G, Kono S, Brandes JC, Grist WJ, Moreno-Williams R, Beitler JJ, Thomas SM, Chen Z, Shin HJ, Grandis JR, Khuri FR, Chen ZG. Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies. Clin Cancer Res. 2013 Mar 1;19(5):1244-56. doi: 10.1158/1078-0432.CCR-12-3149.",
year = "2013",
month = mar,
day = "1",
language = "American English",
journal = "Pharmaceutical Science and Research",
}